News 02/08/2021

Leicester’s Hospitals Awards Deenova a Unit Dose Pharmacy Automation 15 Year Contract

MILAN–(BUSINESS WIRE)–Deenova reported today it signed its first ever contract in the United Kingdom, and established operations in Europe’s second largest GDP health care market, with the NHS being the eight largest employer in the world. Deenova was selected by University Hospitals of Leicester NHS Trust as the best solution amongst 8 of Deenova‘s competitors in United Kingdom and the United States of America.

Claire Ellwood, chief pharmacist at University Hospitals of Leicester NHS Trust, said: “We’re proud to be working with Deenova to deploy the first unit dose closed loop medicines management system in the UK. Every year, we administer millions of medication doses so it’s vital our processes are as safe and efficient as possible. The partnership with Deenova will increase automation within our medication processes helping to reduce errors and wastage as well as freeing up staff time for other care and tasks. After a successful pilot, we are pleased to start planning the roll out across our three hospitals. This programme will ensure the right medicines are in the right place at the right time and will undoubtedly improve care for our patients.”

Giorgio Pavesi, Managing Director of Deenova in Italy stated: “I am extremely proud of the teamwork and dedication exhibited by our employees and those of University Hospitals of Leicester NHS Trust, proving to the health care industry the patient safety and economic advantages of Deenova´s unique Closed-Loop Medication Unit Dose management system and services, as evidenced by the report issued by the East Midlands Academic Health Science Network (AHSN) undertaking an 18 month evaluation of Deenova solutions. The published results included: 25% reduction in the consumption (and costs) of medicines; 40% reduction in the number of items held in the ward stock cupboard, 60% reduction in medicines wastage, and a reduction in missed doses due to medicine not available on wards from 10% to 1.2%, amongst other patient safety and economical benefits, leading to this award.”

Deenova plans to fulfill University Hospitals of Leicester NHS Trust’s contract award with delivery, installation and full service/support for 3 All-in-1 and 1 Acced Packaging Robots, 56 All-in-1 Station Medication Dispensing Robots, and more than 100 All-in-1 Trolleys with secure bed-side verification.

East Midlands AHSN Commercial Director, Tim Robinson, said: “A key role of AHSNs is to help build collaboration across sectors, and in particular to connect commercial innovators with the heath and care organisations that could benefit from their innovations. With this in mind, we welcome the progress made in Leicester – this is a great example of how the NHS and commercial sector can work in partnership. As well as the potential to benefit patients and generate efficiencies, we also welcome the investment into the East Midlands and the jobs this partnership will create.”

Information

Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and making the best use of staff time. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%. Please visit www.deenova.com for additional information on its market leading solutions.

University Hospitals of Leicester NHS Trust: Every day at Leicester’s Hospitals we save lives, improve lives and usher in new life. We want to continue to improve everything that we do, so that we can achieve our vision: Caring at its best for every patient, every time. As one of the largest NHS Trusts in the country, our contribution goes beyond health; we are the largest employer in our region, we educate and train the staff of the future, push the boundaries of research and with our £1bn turnover are an economic engine for East Midlands and beyond. This is a particularly exciting time for Leicester’s Hospitals. We have been given £450m to reconfigure services and build new hospitals. This will include a new Children’s Hospital, Maternity Hospital, Treatment Centre and two new Intensive Care Units. For more information please visit: www.leicestershospitals.nhs.uk

The East Midlands Academic Health Science Network (EMAHSN) is one of 15 Academic Health Science Networks in England that operate as the innovation arm of the NHS. AHSNs bring together the NHS, universities, industry and social care to transform health and stimulate economic growth. In the East Midlands our current priorities focus on identifying and spreading innovations that respond to the COVID-19 pandemic and the recovery of services, along with priority themes including mental health, patient safety and optimising medicines. For more information please visit: www.emahsn.org.uk

News 12/07/2021

Deenova Expands its Italy Winning Streak with 9 Year Tender at ASST Vimercate Hospitals

MILAN–(BUSINESS WIRE)–Deenova today publicly disclosed that its remarkable European market success in 2020 steadily expanded to Italy during 2021, with the recent Public Tender Award won by Deenova at ASST Vimercate Hospitals for multiple D1 unit-dose robots including 6 All-In-1 Stations, 40 modules of Barcode, Fridge and/or Narcotic cabinets, and the continuous utilisation of Deenova’s world-class of full service unit-dose and multi-dose medications solutions.

Giorgio Pavesi, Managing Director of Deenova in Italy stated: “It is a confirmation of our European market momentum that started in 2020, to combine new business robot and service contracts at premier hospitals in Europe with additional purchase of technologies and complex services by previous Deenova customers, clearly showing a high level of continued satisfaction with our automation solutions among our existing customer base, such as Vimercate Hospital.”

ASST Vimercate Hospitals are 5 state-of-the-art acute and non acute hospitals in the territory of Brianza, where architecture, technology and organisation are all aimed at placing the patient at the centre of the logistic and diagnostic-therapeutic paths. They include: Hospital of Vimercate, Hospital Presidium of Desio, Hospital of Carate Brianza, Seregno Hospital Presidium, Presidio Ospedaliera di Giussano with approximately 900 beds.

Christophe Jaffuel, Deenova Chief Commercial Officer, stated: “These 2 latest multi-year Public Tender wins (San Camillo and ASST Vimercate) highlight Deenova main differentiating characteristics compared to other suppliers: patient care crafted for compliance, better safety and therapy compliance, and 24/7 availability.”

Since 2004, Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and medical devices traceability in the healthcare industry, anytime and anywhere.

Deenova’s unique and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff.

Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

News 06/05/2021

Deenova Keeps Smashing New Sales Records in 2022 France’s Pharmacy Automation Market

MILAN–(BUSINESS WIRE)–Deenova announced today it keeps its record-breaking market momentum started in 2021, by winning competitive public tenders at Resah for 6 D3 ACCED Robots and multiple D3 Astus medication solutions to be operated around the clock at Nimes University Hospital, Centre Hospitalier Intercommunal Eaubonne Montmorency-Simone Veil in Sud Val d’Oise, and finally Centre Hospitalier Sainte-Marie Le Puy-en-Velay.

Christophe Jaffuel, Deenova Chief Commercial Officer, stated: “I am very proud France continues to lead Deenova’s international growth for 2 years in a row. Our team latest 3 competitive wins highlight Deenova main differentiating characteristics over our competition, especially in France: Patient Care Crafted for Better Safety and Greater Therapy Compliance, as well as 24/7 availability, a key component of customer needs”.

Loïc Bessin, Managing Director of Deenova in France stated: “I am delighted to welcome 3 new groups of hospital customers to the fast-growing Deenova family in Europe. It is indeed a huge milestone for our company and for our customers to witness first-hand the unparalleled and sustained recognition and success we are receiving over the last 2 years.”

Nimes University Hospital, founded in 1958, is a reference center of medical and surgical specialties, with the priorities of prevention, health education, access to care and fight against social exclusion.

Centre Hospitalier Intercommunal Eaubonne Montmorency-Simone Veil is a key public health player in the Val d’Oise Area with a diversified healthcare offer: medicine, surgery, residential facilities for dependent elderly people and a long-term care unit, psychiatric care, rehabilitation services, etc.

Centre Hospitalier Sainte-Marie Le Puy-en-Velay was created in 1850 by the nuns of the Congregation Sainte-Marie de L’Assomption de PRIVAS. The evolution of mental health care has led the hospital towards elderly, disabled adults and dependent people over the entire Haute-Loire, with home care services, therapeutic reception centers, mobile psychiatry, long-stay unit, etc.

Resah is a public interest group (GIP) created in 2007 to support the pooling of hospital purchases for the Ile-de-France region, in collaboration with Achat Hopital.

Deenova is the undisputed leading supplier of mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere.

Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff.

Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

News 14/04/2021

Deenova Wins First Private Contract in Spain for Hospital Centro de Andalucía de Lucena

MILAN–(BUSINESS WIRE)–Deenova announced today that its unrivalled market momentum unceasingly expands to Spain´s private hospital market, with its first award for won by Deenova in cooperation with Algalasa at Hospital Centro de Andalucía at Lucena, Cordoba, part of the new health enterprise Amaveca Salud.

Gaspar G. De Viedma, Vice Chairman of the Deenova Board of Directors stated:

“I am happy to see the first results of the Deenova´s cooperation with our partnership with Algalasa in such a short period of time, and together with our prior award at Bellvitge University Hospital in Barcelona to demonstrate once again Deenova´s unique scalability in hospitals ranging from 100 to 2.000 beds, with the installation of the ACCED and ASTUS mechatronic medication solutions in 2022.”

Jose Luis Temes, M.D., Algalasa’s President and former Sub-secretary of Health at Spain Ministry of Health, Director of National Health Service in Spain, and Managing Director of multiple Spanish hospitals, including Foundation Jimenez Diaz, Hospital La Paz, and Hospital Queen Sofia, added: “This milestone was possible thanks to the hospital owners understanding of the importance of closing the loop of the medication, from prescription to patient administration, and the unique Deenova’s technology. Centro de Andalucía in Lucena will be a reference in patient safety, staff satisfaction, quality and efficiency of pharmacy processes.”

Hospital Centro de Andalucía de Lucena is located in the Andalucian city of Lucena in Cordoba. With 350 employees serving up to 200 beds, including surgery, a diagnostic area, analysis, a day hospital and physiotherapy, among other services. Its innovative new construction has been equipped with all kinds of details, such as domotic rooms, and patient entertainment systems (tablets, televisions, etc).

Deenova is the undisputed leading supplier of mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere.

Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff.

Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

 

News 18/03/2021

Deenova Wins Tender at San Camillo Hospital expanding its European Win Streak to Italy

MILAN–(BUSINESS WIRE)–Deenova today publicly disclosed that its unprecedented market success in 2020 relentlessly expanded to Italy in 2021, with the recent Public Tender Award won at San Camillo Forlanini Hospital for multiple unit-dose robots, electronic prescription, automated medical devices traceability, and a full service model for the utilisation of Deenova’s world-class solutions.

Giorgio Pavesi, Managing Director of Deenova in Italy stated: “It is a testament to Deenova European market momentum started in 2020 to combine new business robot and service contracts at premier hospitals in Europe, with additional purchase of technologies and complex services by previous Deenova customers, clearly showing a high level of continued satisfaction with our automation solutions amongst our existing customer base, such as San Camillo Forlanini Hospital.”

San Camillo – Forlanini Hospital is a major public health institution located in Rome with 730 patient beds and is included in the regional health system as a HUB center. Patient Care Departments and Administration offices are distributed over 14 pavilions, covering a total area of 238,000 m².

Since 2004, Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

News 13/01/2021

Patient Care Crafted for Better Safety and Greater Therapy Compliance

CIO APPLICATIONS EUROPE — In the healthcare sector, the ‘applicability of technology’ carries far greater importance than the technology itself. Technology today is more so about than finding the right equilibrium of cost, applicability, and benefits. Such an equilibrium would eliminate human errors and increase treatment compliance, effectively leading to better quality of care for patients, while enhancing the productivity of healthcare professionals. Deenova—a supplier of robotics and automation solutions for closed-loop medications and medical devices traceability—has achieved this equilibrium through its mechatronics proficiency. From prescription to administration to bed side verification, Deenova’s technological solutions are designed to be cost-effective, intuitive, and sensitive. The company’s All-in-one repackaging robot creates unit dose, repacks and labels all pharmaceutical formats: oral solid and liquid medications, such as vials, syringes, ampoules, and all other formats of patches sachet, and suppositories. These unit doses are then loaded on to the company’s All-in-one station, located discretely at various patient care departments across hospitals and pharmacies. Alongside these solutions, Deenova also offers Orbit – a proprietary software for e-prescribing and micro logistics management, capable of automatically generating a reordering list of unit doses based on doctor recommendations in realtime. The system caters to the fully automated therapy preparations and dispensation through the Deenova All-in-one Station, which loads the specific unit doses on to the All-in-one Trolley. This comprehensive system empowers nurses to initiate therapy administration with the All-in-one Trolly, thereby ensuring that the right therapy is given to the right patient by scanning the patient’s identification tag. Conclusively, Orbit orchestrates a decentralized model for patient care, wherein, the unit doses are produced centrally while the patient-specific therapies are prepared in the corresponding care departments.

“We do not position ourselves as a Technology Vendor, but rather provision a unique business model, in which, we partner with healthcare facilities and guarantee Full service 24/7 thanks to the combination of proprietary hardware, software and people,” explains Christophe Jaffuel, the chief commercial officer of the company. Deenova’s Orbit software combines e-prescribing and micro logistics, showcasing the ability the interoperate alongside 50 other solutions. Jaffuel terms this applicability as a ‘string advantage for customers’ that require cross-platform solutions.
Comprehending these string of benefits, it is safe to say that Deenova has created a reliable and efficient patient care ecosystem with multiple use cases. For instance, healthcare facilities seeking to improve medication management can reduce the cost of administering medications in their facilities while minimizing error and increasing patientnurse engagements. This merit alone translates to higher productivity among nurses and lower financial overheads involved in medication management– an expenditure that is skyrocketing in the current day and age. More importantly, Deenova reduces inventory management, eliminates duplication, ensures traceability of medication, provisions governance and control over clinical and logistics processes.
These value propositions are driven by Deenova’s people and the patient-centric vision that the company upholds through its mechatronics portfolio of products, designed to overhaul medication traceability. The company has recently introduced these functions into the retail pharmacy sector as well, facilitating home delivery of medications. “It is not difficult to picture a world where the patients needing medication could benefit from online prescriptions, telemedicine and e-pharmacy, while receiving personalized therapies at the comfort of their homes, in the right quantity, for the exact duration of the treatment, with necessary support,” adds Jaffuel. Without a hint of doubt, Deenova has materialized this world, all the while increasing safety and therapy compliance.

Read the full magazine Cio Applications Europe

 

 

News 12/01/2021

Deenova Wins Top 10 Robotics Award, and AP-HP and Francois Quesnay Public Tenders

MILAN–(BUSINESS WIRE)–Deenova separately announced today three key awards won by our innovative mechatronic service solutions company, the 2020 Top 10 Robotics Solutions by CIO Applications Europe and Deenova winning its entry through its latest Resah public tender win for its D3 ACCED Robot to be operated 24/7 at prestigious AP-HP (l’Assistance Publique-Hôpitaux de Paris) in Hendaye and François Quesnay Hospital Center for 2 of the company D3 ASTUS solutions.

Christophe Jaffuel, Deenova Chief Commercial Officer, stated: “We finished 2020 and started 2021 with a bang, I am very proud of our team latest unparalleled accomplishments in our industry. These 2 latest company wins highlight Deenova main differentiating characteristics, patient care crafted for better safety and greater therapy compliance, and 24/7 availability, a key component of AP-HP needs”.

AP-HP (l’Assistance Publique-Hôpitaux de Paris) is a globally recognized university hospital center with a European dimension. Its 39 hospitals welcome more than 10 million patients per year: consultations, emergencies, hospitalizations and finally home care, at all ages of life, providing public health service for all, 24/7.

François Quesnay Hospital Center is a 612-bed hospital in the Paris metropolitan area, with a budget of 125 million euros and 175 doctors.

CIO Applications Europe magazine stands out with its unique approach of learning from peers approach offering professionals the most comprehensive collection of technology trends, being the single most successful initiative Pan-Europe.

Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

News 08/01/2021

San Martino Hospital in Genoa is among the winners of ‘Lean Health Award 2020’, thanks to Deenova solutions

‘Lean Healthcare and Lifescience Award’ rewards the best healthcare reorganization projects in Italy. San Martino Hospital was among the winners for the best project in the field of ‘Business risk management’.


San Martino Hospital was awarded as best project in ‘Business risks management’ at ‘Lean Healthcare and Lifescience Award 2020’. The event, organized by Telos Management Consulting in collaboration with Federsanità, Aiop, Fiaso and University of Siena, rewards the best health reorganization projects in Italy.

The project, which is part of San Martino Hospital strategy  in investing in medications computerized management, is called ‘Direct-Sofia‘ and is the revision of direct distribution of medication to Hospital patients (direct distribution is meant as medications dispensing, through healthcare facilities, to the out-patients, for home administration) with the purpose of increasing safety in therapy distribution, thanks to the concomitant adoption of a new application as unique tool to manage prescription phase and medications distribution to patients.

The systematic presence of a computerized medical prescription in the first phase of medications distribution will allow to enhance traceability along the entire path, through the identification of barcode on medication boxes and to verify timely correspondence to prescription and to patient’s registry. All the information recorded gave, at the same time, the possibility to hospital pharmacist to conduct useful analyzes on patient’s compliance with therapeutic plan and, consequently, on therapy effectiveness.

Click here to review the presentation of the ‘Direct-Sofia’ project of San Martino Polyclinic Hospital.

https://www.ospedalesanmartino.it/

News 16/12/2020

Deenova Accomplishes the Design, Re-Branding, and Virtual Tour of its World Class Solutions

MILAN–(BUSINESS WIRE)–Deenova announced today the completion of company re-branding and the re-design its website in five languages, especially developed for Covid-19 times, including Virtual Tour and Self-Configuration tools for its world class solutions, coinciding with the company’s unprecedented international success in 2020.

Gaspar G. De Viedma, Vice Chairman of Deenova Board of Directors stated: “Deenova sales and marketing team has just established a new industry standard for how Pharmacy Automation solutions are introduced to the medical industry, automatically configured in Deenova´s web site, and tied to specific evidence based benefits and R.O.I. Over my 35 years of health care and technology industry experience, I have never witnessed anything that comes even close to Deenova´s launch, once more demonstrating why it holds its market leading position.”

Deenova D1 Series error-free mechatronics technology is the first and only fully automated closed loop solution for the management of both medication and medical supplies, ensuring total traceability from prescription to bed side verification. Including the All-in-1 robot, All-in-1 Station dispensing unit, All-in-1 Trolley with secure bed-side verification, and finally Orbit E-Prescribing and micrologistic management software.

Deenova D3 Series for the automatic repackaging and dispensation of personalized therapies in unit doses include Acced, a completely autonomous robot potentially used 24/7, that prepares the unit doses from previously loaded medication blisters, and Astus, installed directly in the patient care departments for controlled storage and administration of all types of medication therapies.

Deenova D8 Series, complementary to Deenova D1 Series, managing hospital micrologistics and full traceability of medical supplies include: Orbit, CheckIn, Sentinel, Sentry, and Frontier.

Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenova’s unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providers’ growing pressures to: simultaneously improve patient safety, reduce therapy errors, minimize waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.

News 02/12/2020

Deenova Bolsters its 2020 Market Momentum in Pharmacy Automation with entry into Poland

MILAN–(BUSINESS WIRE)–Deenova announced today that in continuing its meteoric 2020 business boom, it made its first foray into Eastern Europe with new contracts for delivery of its market leading pharmacy robots and related technologies to Greater Poland Children’s Health Centre in Poznań, with Polish leading equipment company MEDIM in Piaseczno. 

 Piotr Młynarczyk, MEDIM General Manager, stated: “After a long search on a competitive sales process that throughly searched all options for pharmacy unit dose robots, I am very proud to select Deenova for partnership in the project at Greater Poland Children’s Health Centre in Poznań.We chose Deenova solutions, mainly because of their unique technology and business approach to R.O.I.” 

 Christophe Jaffuel, Deenova Chief Commercial Officer, added: “I am extremely excited to have been selected by Greater Poland Children’s Health Centre in Poznań, and Poland medical technology leader MEDIM, especially after their extensive experience comparing and contrasting Deenova´s solutions to those of our competitors. 

 Greater Poland Children’s Health Centre in Poznań is a state of the art 354 new paediatric hospital, one of the largest children hospitals in Poland, opening its doors to patients in 2021, with 9 units and a dozen specialist clinics. 

 MEDIM is a dynamically developing company with 30 years of experience. The company was founded in 1990 and since the beginning of its activity has focused on comprehensive and fully professional service of health care units in the field of innovative and effective medical technologies. Currently, the company is one of the top medical equipment distributors in Poland, employing 80 expert staff. 

 Deenova is the undisputed leading supplier of combined mechatronics (robotic and automation) solutions for closed loop medications and RFID-based medical devices traceability in the healthcare industry, anytime and anywhere. Deenovas unique, patented, and fully integrated solutions have and will greatly contribute to ease healthcare providersgrowing pressures to: simultaneously improve patient safety, reduce therapy errors, minimise waste and controlled substance diversion, contain costs, and diminish the gap between rising patient volume/acuity and scarce medical staff. Deenova guarantees the simplification of all processes related to the management of medications and implantable/disposable medical devices with an expected cost savings range between 15% and 25%.